RecruitingNot ApplicableNCT06691698

Evaluation of CO-OP for Adolescents With Mild Intellectual Disability

Evaluation of The Cognitive Orientation to Daily Occupational Performance (CO-OP) Approach for Adolescents With Mild Intellectual Disability


Sponsor

Örebro University, Sweden

Enrollment

60 participants

Start Date

Jan 16, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Intellectual disability (ID) affects a person throughout life and includes difficulties to manage what is expected in everyday life based on age. One difficulty is to create strategies for and solve problems related to everyday occupations. Treatment options with good evidence to enhance occupational performance for persons with ID are limited. The Cognitive Orientation to Daily Occupational Performance (CO-OP) is an approach with good evidence within other diagnostic groups, i.e. adolescents with cerebral palsy. CO-OP has a unique person-centered approach where the person chooses his/her own goals and creates his/her own strategies to reach them. Initial research shows potential for CO-OP with adolescents with ID, although due to scientific flaws there is still a lack of evidence regarding feasibility and effectiveness for adolescents with ID. Based on the results with other diagnostic groups and clinical knowledge and experience, CO-OP can be assumed to be feasible and effective for adolescents with ID and to have a long term effect transferred to everyday life in a way other treatment options do not. The aim of the project is to describe and evaluate CO-OP for adolescents with mild ID. Participants will be adolescents aged 13-17 and their parents. The project is designed as a feasibility study with two qualitative, one quantitative and one mixed method data collection. The quantitative data will be ordinal and nominal data from observational and self-assessment assessments. The mixed methods include comparison between filmed sessions and the CO-OP manual, use of field notes to analyse fidelity and needs for adaptations, and comparison between the CO-OP manual and policy documents. The qualitative outcome will be experiences by the adolescents and perceptions of CO-OP by parents.


Eligibility

Min Age: 13 YearsMax Age: 17 Years

Plain Language Summary

Simplified for easier understanding

This study is evaluating a goal-setting intervention called CO-OP (Cognitive Orientation to daily Occupational Performance) for teenagers with mild intellectual disability. CO-OP helps young people develop strategies to achieve their own chosen goals in daily life and build independence. **You may be eligible if...** - You are between 13 and 17 years old - You have been diagnosed with mild intellectual disability - You are motivated to work on goals that matter to you - You are able to meet once a week for ten weeks - You have a parent or caregiver who can support you **You may NOT be eligible if...** - You have a movement disorder like cerebral palsy - You have been diagnosed with ADHD, ADD, or autism spectrum disorder - You have a progressive neurological condition - You need an interpreter or use pictures/signs to communicate Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERThe Cognitive Orientation to Daily Occupational Performance Approach

CO-OP is a client-centred, performance-based, problem-solving focused, occupation-focused and occupation-based intervention. In CO-OP the person is guided to use a meta-cognitive strategy to find his or her own strategies for specific activities. The main purpose is to enable meta-cognitive thinking in every day activities, leading to enhanced self-efficacy, occupational performance and independency.


Locations(2)

Region Skåne

Kristianstad, Skåne County, Sweden

Region Värmland

Karlstad, Värmland County, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06691698


Related Trials